RECRUITING

Effect of Meal Composition and Timing Modification on Glucose Metabolism, Body Temperature and Sleep

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of our study is to understand the impact of different meal timing alterations on blood sugars, metabolism, microbiome and sleep physiology in people with prediabetes and diabetes; and to study the temperature/heart rate response to different meals in different people.

Official Title

Effect of Meal Composition and Timing Modification on Glucose Metabolism, Body Temperature and Sleep

Quick Facts

Study Start:2023-02-01
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05413928

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Be 18 years of age or older;
  2. * Not be pregnant, if female;
  3. * Be generally healthy (with no apparent symptoms at the time of enrollment)
  4. * Patients with prediabetes or diet- controlled or type 2 diabetes or controlled with metformin, will also be allowed to participate.
  5. * Be willing to provide written informed consent for all study procedures.
  1. * major organ disease
  2. * pregnant/lactating
  3. * diabetes medications except for metformin
  4. * malabsorptive disorders like celiac sprue
  5. * heavy alcohol use
  6. * use of weight loss medications or specific diets
  7. * weight change \>2 Kg in the last month
  8. * history of bariatric surgery
  9. * Any medical condition that physicians believe would interfere with study participation or evaluation of results
  10. * Mental incapacity and/or cognitive impairment on the part of the patient that would preclude adequate understanding of, or cooperation with, the study protocol.

Contacts and Locations

Study Contact

Alessandra Celli, MS
CONTACT
(650) 725-8491
alessandra.celli@stanford.edu
Dalia Perelman, MS
CONTACT
650-723-4668
daliap@stanford.edu

Principal Investigator

Michael Snyder, PhD
PRINCIPAL_INVESTIGATOR
Stanford University
Heyjun Park, PhD
STUDY_DIRECTOR
Stanford University

Study Locations (Sites)

Stanford University
Stanford, California, 94304
United States

Collaborators and Investigators

Sponsor: Stanford University

  • Michael Snyder, PhD, PRINCIPAL_INVESTIGATOR, Stanford University
  • Heyjun Park, PhD, STUDY_DIRECTOR, Stanford University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-02-01
Study Completion Date2025-12

Study Record Updates

Study Start Date2023-02-01
Study Completion Date2025-12

Terms related to this study

Additional Relevant MeSH Terms

  • PreDiabetes
  • Type 2 Diabetes
  • Healthy